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ABSTRACT Proton magnetic resonance has been used to
monitor binding of choline, a known partial agonist, to acetyl-
choline receptor-enriched membrane preparations from Tor-
pedo californica electroplax. The interaction between choline
and receptor led to a broadening of the resonance of the choline
methyl groups and this effect was reversed by a-bungarotoxin,
a quasi-irreversible antagonist of the acetylcholine receptor.
From the concentration dependence of line broadening the
equilibrium dissociation constant for choline was obtained (Kd
= 190 ± 65 M). The temperature dependence of the parameters
observed in the choline titrations gave an enthalpy of binding
AH < 1.5 kcal/mol and allowed estimates for the dissociation
rate constant of the receptor-choline complex (kdiss > 1.6 X 103
S') and the respective activation energy, Ea (kdis) - 5.5 kcal/
mol. The association of other ligands with the membrane-bound
receptor could also be studied by observing effects of varying
concentrations of such ligands on the choline methyl group
linewidth at a constant choline concentration.
In recent years the application of NMR methodology to bio-
logical systems has yielded a wealth of information regarding
structural and functional aspects of enzymes and proteins in
solution. This has been achieved mainly by approaches such as
direct observation of nuclei of constituent amino acid sidechains
of the macromolecules or observation of perturbations of ligand
nuclei exchanging between free and bound states under dif-
ferent sets of conditions. In order to extend such methods to the
study of membrane-bound macromolecules, the second ap-
proach is the more feasible provided that (i) a high concen-
tration of membrane-bound ligand binding sites can be ob-
tained, (Hi) a ligand is available that is readily observable by
using current NMR instrumentation, and (iMi) the ligand
binding parameters are suitable for study of the exchange be-
tween free and bound states.
The third condition is not fulfilled by agonists such as ace-
tylcholine (AcCho) and carbamylcholine (Carb), because these
ligands have too high an affinity for the AcCho receptor (Ac-
ChoR) under equilibrium conditions. However, all the neces-
sary conditions are met by using choline as a ligand that binds
to membranes highly enriched in the postsynaptic nicotinic
AcChoR. Titration of membrane fragments enriched in Ac-
ChoR (1-3) with choline, a known partial agonist (4), has al-
lowed determination of the choline dissociation constant from
the concentration dependence of the observed linewidth, be-
cause nonspecific broadening was determined to be negligible
by similar titration of membrane fragments in which the Ac-
ChoR agonist binding sites were blocked with a-bungarotoxin
(a-BuTx). The temperature dependence of the dissociation
constant and that of the methyl linewidth at a fixed choline
concentration contained the data necessary for determination
of the enthalpy of binding and for estimation of the apparent
dissociation rate constant and the respective activation energy.
Thus, it is possible to apply a highly informative spectroscopic
technique to the study of membrane-bound receptors for elu-
cidation of structural and kinetic properties.
METHODS AND MATERIALS
Torpedo californica membrane fragments were enriched in
AcChoR by using sucrose density-gradient centrifugation with
a Beckman reorienting-gradient rotor (3). The enriched
membranes were then centrifuged at 100,000 X g, and the
pellet was resuspended in 0.01 M sodium phosphate buffer
made with 99.7% 2H20. After a minimum of 2 hr, the mem-
branes were again pelleted and resuspended in 0.01 M sodium
phosphate buffer made with 100% 2H20 (Bio-Rad). This last
procedure was repeated and the preparation was then ho-
mogenized twice for 30 sec with a VirTis 23 homogenizer op-
erating at maximal speed. Final concentration of AcChoR,
expressed as 1251-labeled a-BuTx sites, was typically 10 MM.
Stock solutions of Carb were freshly made in 100% 2H20. Care
was taken to minimize atmospheric contact in order to maintain
low levels of protiated water, which would lead to technical.
difficulties involving the dynamic range of the spectrom-
eter.
1H spectra were recorded at 100 MHz by using a Varian XL
100-V15 in the Fourier transform mode. Temperatures were
controlled by using a modified Varian variable temperature
unit. Sample volumes were between 1.5 and 2 ml in 12-mm
tubes, which necessitated the use of Teflon Vortex plugs (Wil-
mad, Buena, NJ).
AcChoR concentration was determined by 125I-labeled
a-BuTx binding to AcChoR and subsequent adsorption of the
complex to DEAE-paper discs (5).
RESULTS
Choline Titration. When a relatively low concentration of
choline (200 MtM) was added to a suspension of AcChoR-en-
riched membrane fragments at moderate concentration (10;uM
in a-BuTx binding sites), the linewidth of the three equivalent
choline methyl groups was observed to be substantially broader
than that of choline alone in aqueous solution (Fig. 1 upper).
At a ratio of choline to AcChoR a-BuTx binding sites of 10:1,
Abbreviations: a-BuTx, a-bungarotoxin; Carb, carbamylcholine;
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FIG. 1. (Upper) Proton magnetic resonance spectra of choline
methyl groups at various concentrations of choline. All spectra were
recorded in 10 mM Pi buffer (2H20), pH 7.4, containing membrane
fragments with 5 AM AcChoR at 4.60C. The top spectrum was re-
corded 20 min after the addition of 10 uM a-BuTx to the above so-
lution in which the choline concentration was 1.1 mM. (Lower) Plot
of the spectra in Upper by using Eq. 2; (rob,, - rF)Y versus [choline].
The line was determined by a weighted linear least-squares fit.
a wide (n15 Hz) line was observed and, as the ratio of choline
to AcChoR was increased, the observed linewidth decreased
until an apparently constant value was obtained when the
choline to AcChoR site ratio was on the-order of 100:1. When
the same experiment was performed with membrane fragments
that had been treated with a-BuTx, a constant and narrow
linewidth was observed, independent of the choline concen-
tration. These observations are consistent with the hypothesis
that the linebroadening was due to a specific interaction of
choline with the AcChoR. No change in chemical shift was
observed, and it was considered that this quantity was the same
for both bound and free states. In the case of weak binding (see
below), the free species is the one observed and, if there is only
one bound state, the equation describing the-linewidth is:
robs - rF - lb/l,
7r(T2b + tb) [1]
where Fobs is the width of the observed lorentzian line at half
its height, rF is the width of the line under conditions in which
the specific broadening is abolished, lb/lo is the fraction of the
ligand bound (with free ligand in great excess over bound), and
T2b and tb are the spin-spin relaxation time and average resi-
dence time of the bound ligand, respectively (6). At a given
temperature, T2b and tb are constant, and the observed
broadening is solely a reflection of the fraction of the ligand
bound. Thus, the dissociation constant for the ligand may be
obtained by plotting (robs- rF)- versus total ligand con-
centration, lo, (Fig. 1 lower), because expressing lb/lo in terms
of lo and Kd results in:
I 7r(T2b+tb)
robs -Fr- r0 l +K) [2]
Here, ro is the total concentration of binding sites and Kd is the
apparent dissociation constant of the complex.
Several titrations of choline-receptor association at different
temperatures were conducted to determine the thermodynamic
parameters of the interaction between choline and the AcChoR.
For the equilibrium constant little or no temperature depen-
dence was found within our limits of error (Table 1), and it was
concluded that AH for this binding was small.
The temperature dependence of the slopes (S) of the sem-
ireciprocal plots, as in Fig. 1 lower, also contains important
information:
S =-(T2b + tb)
ro
[3]
The two parameters, T2b and tb, are expected to have opposite
temperature dependences (7, 8). We observed a decrease in
slope with increasing temperature (see Table 1) and an increase
in the observed linewidth at low saturation of the AcChoR with
choline. This indicates (see Discussion) that tb > T2b. Because
tb, the lifetime of the complex, is equal to I/kdiss, where kdiss
is the (apparent) dissociation rate constant of the complex, one
estimates from the data in Table 1 that kdiss > 1.6 X 103 S-1 at
180C.
The temperature dependence of the slope (Eq. 3) yields the
activation energy for kdiss with Ea (kdiss) = 5 i 2 kcal/mol. A
statistically independent estimate of E. (kdi~s) is obtained from
an Arrhenius plot of log (rFj - rF) at a fixed choline concen-
tration versus 1/T (see Fig. 2). Because Kd is essentially tem-
perature independent in the temperature range studied (see
above and Table 1), the observed slope in Fig: 2 reflects the
activation energy of the process characterized by tb, which in
this case was found to be 5.5 kcal/mol. Both values for Ea are
in good agreement.
Competition Studies. Competition studies with radiolabeled
ligands have shown that different agonists apparently bind to
the same site of the AcChoR from Torpedo (9, 10) or Electro-
phorus (11) membranes. Therefore, addition of the agonist
Carb should reduce line broadening due to its interaction with
the binding site of the ligand being observed (choline). Because
Carb affinity for the receptor is much higher than that of
choline (10, 12-14), a low concentration of Carb would be un-
detected in the NMR spectrum but would be expected to nar-
row the choline signal substantially. This behavior was-observed,
and a complete titration with Carb at fixed choline concen-
tration (Fig. 3) resulted in an apparent Kd for Carb of 3.5 I 0.1
AiM when the data were plotted by using Eq. 2. This value must
be corrected for the effect of choline competition by using the
Table 1. Equilibrium dissociation constants and maximum
dissociation rates for the choline-AcChoR complex at
various temperatures
T,-C
4.6
10.5
18.0
26.0
33.5
Kd, AM
195 I 30
220 I 35
300 i 70
150 + 20
100 i 50
(T2b + tb), sec
9.1 + 1.4 X 1o-4
1.05 + 0.17 x 10-3
7.9 + 1.8 X 10-4
4.0 + 0.5 x 10-4
4.3±2.1 X 10-4
Average value 190 ± 65
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FIG. 2. Arrhenius plot constructed by using data from proton
magnetic resonance spectra of a mixture of 0.7 mM choline and Ac-
ChoR-enriched membrane fragments (125I-labeled a-BuTx site
concentration = 22 MM) recorded at various temperatures. The plot
is of log (rob. TF) versus l/T and yields Ea = 5.5 kcal/mol.
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FIG. 3. (Lower) Titration of choline-AcChoR complex with Carb.
The experiment monitors the variation of the choline linewidth with
Carb concentration. The mixture contained AcChoR-enriched
membrane fragments (20 MtM 125I-labeled a-BuTx sites) and 0.9mM
choline in 10mM Pi buffer (2H20), pH 7.4, at 150C. The plot shows
(Fo1, - rF)' versus [Carb]. The line is a weighted linear least-squares
fit, giving an apparentKd of 3.5 4 0.1 ,M. (Upper) Titration of cho-
line-AcChoR complex with NaCl. The conditions are as in Lower,
with (rob,, - rF)1l versus [NaClJ plotted. The line is a weighted
least-squares fit, giving an apparent Kd of 260 ± 10 mM.
formula Kd = Kapp [1 + S./Ko]-1, where Kd is the true disso-
ciation constant, Kapp is the apparent dissociation constant
measured, So is the concentration of the competing ligand
(choline in this case), and K. is the dissociation constant of this
competing ligand. The corrected Kd for Carb was 0.5 I 0.1
,uM.
It has been shown that monovalent cations decrease the
second-order rate constant for 125I-labeled a-BuTx binding to
(15) and the affinity of the fluorescent antagonist 1,10-bis(3-
aminopyridinium)-decane diiodide for (16) solubilized purified
AcChoR. Both of these studies showed that monovalent cations
have apparent binding constants of 5 mM. On the other hand
sodium chloride, in the 5-50 mM range, had little or no effect
on the binding-of the agonist AcCho to solubilized purified
AcChoR (T. Moody and M. A. Raftery, unpublished results).
*By using the same methods employed for Carb, we obtained
a Ki (apparent) for NaCl of 260 + 10 mM, indicating a much
weaker effect of salt on the binding of the partial agonist choline
than was observed on the binding of antagonist (see above).
The dissociation constant for choline was also determined by
inhibition of the kinetics of 125I-labeled a-BuTx-AcChoR as-
sociation (12) in buffer of composition identical to that used in
the NMR experiments (i.e., containing 2H20). The value ob-
tained (120 + 50 AM) was in good agreement with that obtained
from the NMR data [Kd (average) = 190 ± 65 AM]. The same
experiment performed with the buffer made in protiated water
resulted in essentially the same Kd.
DISCUSSION
The studies we describe are based on observation of a pertur-
bation in the 1H-NMR spectrum of a partial agonist induced
by binding interactions with the AcChoR in its native mem-
brane environment. The effect is specific because it can be
completely blocked by pretreatment of the membranes with
a-BuTx, which specifically and competitively blocks ligand
binding to the AcChoR (17). The binding of a-BuTx should not
affect any linebroadening due to nonspecific interactions, and
the data for rF therefore reflect all NMR linebroadening except
that due to specific ligand binding at the AcChoR agonist
binding site.
The data were analyzed according to Eq. 1, which is a special
case of a more general formula derived by Swift and Connick
(6) from modified Bloch equations containing terms for
chemical exchange (18). The main assumptions leading to Eq.
1 are (i) there are only two kinds of environment for the nucleus
(i.e., bound and free), (ii) the free nuclei are always in excess
over the bound species and are therefore the ones observed, and
(iii) there is no change in chemical shift due to binding.
Assumptions ii and iii were experimentally fulfilled in that
we did not observe a chemical shift difference between bound
and free-ligand, and the concentrations of ligand binding sites
used were Ro t 10 MM << Kd ; 200 AM, so that at all ligand
concentrations only a small fraction of the total ligand present
was bound. Assumption i was made for the sake of mathe-
matical simplicity because the original formulae of Swift and
Connick are complex and would not allow unambiguous de-
termination of the many parameters they contain.
VT
#1.1 \, T
II
I I I \
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Plotting the observed half-width of the resonances according
to Eq. 2 directly yielded the equilibrium constant, Kd. The
value of 190 i 65 yuM for choline is in agreement with that
obtained from inhibition of the kinetics of 125I-labeled a-BuTx
binding in the same medium (120 + 50 jiM). These values are
more than 2 times higher than those determined in 4 mM
protiated buffer containing calcium, where we found a value
of 51 +4AM by 125I-labeled a-BuTx inhibition (12) and about
25 jiM by using the fluorescence probe ethidium (13, 14). An
analogous effect was observed for Carb, for which we found
Ki = 0.5 + 0.1 jM from competition with choline in our NMR
experiments in deuterated, calcium-free buffer compared to
0.33 i 0.05 jiM by using radiolabeled Carb in calcium-free
protiated buffer (M. Schimerlik and M. A. Raftery, unpublished
results). On the other hand, values of 0.05-0.12 AiM were de-
termined for the Kd in calcium-containing buffers by using
various experimental approaches (13, 14, 17, 19).
The finding of similar equilibrium constants for choline by
inhibition of 125I-labeled a-BuTx binding kinetics in protiated
and deuterated buffers seems to indicate that the lack of cal-
cium is primarily responsible for the high Kd values. This
conclusion is in agreement with the observation of Cohen et al.
(20) that calcium increases the affinity of the membrane-bound
AcChoR for cholinergic ligands. Choline titrations at different
temperatures showed essentially no temperature dependence
of the equilibrium constant, and the enthalpy of binding was
estimated to be >1.5 kcal/mol. Therefore, binding of choline
to AcChoR is mainly entropy driven [AS 20 J/(mol-K)]. The
increased entropy of the complex (compared to the free com-
ponents) could be due to higher internal flexibility in the
complex or a decreased exposure of hydrophobic surfaces of
the complex to the solvent. A ligand-induced conformational
change of the AcChoR provides a plausible explanation for both
cases. There is indeed independent evidence for such an (cho-
line) induced conformational transition of the AcChoR (14, 17,
21). We are not aware of other determinations of the change
in enthalpy accompanying agonist binding to the membrane-
bound AcChoR. With solubilized purified AcChoR from
Electrophorus, a considerable positive change in enthalpy was
observed upon agonist binding (AH - 20-30 kcal/mol) which
was overcompensated by unusually large positive changes in
entropy, AS - 100-120 J/(mol.K) (22).
Further kinetic results can be inferred from the observed
temperature dependence. The denominator of Eq. 1 is the sum
of two terms, T2b and tb. Because 1/tb is the average exchange
rate of the ligand-receptor complex, the data obtained from
a titration allows us to place a lower limit on the exchange rate.
How close this limit is to the actual value depends on the con-
tribution T2b makes to the denominator. T2b is not easily
evaluated; however, the temperature dependence of the line-
width gives a good indication of the relative sizes of T2b and tb
due to their opposite temperature dependences (7, 8). The ex-
change rate (1/tb) increases with temperature, exposing a larger
proportion of the total choline spin population to the bound
environment, and this results in a broadening of the observed
line as temperature increases. T2b is expected to have the op-
posite behavior because the faster molecular motions associated
with higher temperature usually result in decreased effec-
tiveness of relaxation processes and thus larger values for T2b
(7, 8). A system in which T2b was the dominant term in Eq. 1
would be expected to have a decreased linewidth at higher
temperature. Our observation that the linewidth increased with
temperature (Fig. 2) indicates that tb is the dominant term, and,
therefore, we may place meaningful lower limits on the disso-
ciation rate of the agonist from the receptor complex. The
dissociation rates determined (Table 1) are on the order of 2.5
X 103 s-1 at room temperature. Assuming a simple L + R
LR mechanism, the lower limit of the association rate constant,
kass, can be calculated from Kd and kdi,, as kass = kdiss/Kd = 1.5
X 107 M-1 s-l. Values in this range have been observed in
stopped-flow experiments for binding of a few agonists to
membrane-bound (21, 23) or solubilized purified (24) Torpedo
AcChoR as well as with Electrophorus cells in electrophysio-
logical measurements (25), and they are on the threshold of
being diffusion controlled. The activation energy associated
with ka is estimated as Ea (kass) = Ea (kdiss)-AH 5 kcal/
mol, a value also somewhat high for a diffusion-controlled
step.
Use of a simple binding mechanism has been widely dis-
cussed (4) for choline, a partial agonist; i.e.,
L + R L R L R*,
where formation of open channels, LR*, is considered to be
much less frequent than for full agonists, such as AcCho. Such
a situation is in fact favorable for studies of the binding process,
rather than activation of channels. It should be kept in mind,
however, that our studies have been conducted under equi-
librium conditions. We have shown (17) that choline, like other
agonists, effectively converts the receptor to a state of higher
ligand affinity considered to represent an in vitro desensit-
ized i.e., closed-channel-conformation (26).
There is a possibility that more than one class of agonist
binding site exists. The NMR data seem to reflect only a single
class of sites; however, sites of significantly higher affinity would
be saturated to such an extent as to make a negligible contri-
bution to the observed linewidth. Sites of much lower affinity
(14) would escape detection of the transverse relaxation time,
T2b, because the choline methyl protons bound to these sites is
similar to that for free choline, as is expected for very loose
complexes.
In conclusion, NMR has been shown to be a promising ex-
perimental method for investigating agonist binding to the
purified AcChoR in its membrane environment. Results that
can be compared agree well with those obtained by using other
methods, complications due to nonspecific binding effects or
probe-induced artifacts can be avoided, and the approach has
provided a means of estimating parameters not previously
determined.
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